logo
'My wife was told she had a trapped nerve - now we have been robbed of her'

'My wife was told she had a trapped nerve - now we have been robbed of her'

Daily Mirror7 days ago
Helen Arthur, 57, was initially told her back pain was probably a trapped nerve
A mum-of-two died from an aggressive brain tumour after her back pain was initially attributed to a trapped nerve. Helen Arthur, 57, began feeling unwell on Good Friday in April 2019, suffering from persistent back pain and visual disturbances.

Her GP initially believed it was a trapped nerve, but Helen's symptoms persisted. Following the onset of headaches, an eye test led her optician to suspect a minor stroke, prompting a hospital referral.

A CT scan at the hospital uncovered a mass on Helen's brain, leading to a diagnosis of glioblastoma, a relentless and incurable brain tumour. In May 2019, Helen faced surgery to remove the tumour, which was followed by six months of chemotherapy and radiotherapy combined.

Despite the treatment, a routine scan in 2021 revealed the cancer had returned and Helen faced another round of radiotherapy and chemotherapy. Sadly, further MRI scans showed the development of multiple inoperable tumours, and Helen's condition declined too rapidly for further intervention.
Helen, hailing from Merthyr Tydfil in Wales, succumbed to the disease in May 2022, three years after her initial operation.
Helen's husband Brent Arthur said: "We were told Helen had a brain tumour, which was a complete shock. The doctors said most people survive just two to three years.

"Words left me, I was speechless. We were told there would be a recurrence, but it took us by surprise, we thought we had more time."
Helen's initial CT scan at Prince Charles Hospital in Merthyr Tydfil, uncovered a mass, leading to her transfer to the University Hospital of Wales in Cardiff. Brent recounted the harrowing moment he received the call from his son in May 2019, breaking the tragic news.

He said: "I wasn't feeling well, so I went to bed and expected our son Benjamin and Helen to be home within a couple of hours. I got a call from Benjamin saying I needed to go to the hospital.
"Confused as to what could be wrong, I went. That was when our lives changed."
Following successful surgery and six months of chemotherapy and radiotherapy, Helen seemed to be on the mend, with regular scans tracking her progress as she embraced life and cherished moments with her family and grandchildren.

However, a scan towards the end of 2021 revealed the cancer had returned. Helen faced another round of treatment, enduring more chemotherapy and radiotherapy.
An MRI scan in April 2022 showed the development of multiple inoperable tumours. Just seven days later, it was discovered that Helen had an extremely rare genetic mutation, potentially treatable with specific drugs.
Tragically, by then, Helen's health had declined too far for treatment to be an option.

Brent said: "We were all shocked and devastated. We spent as much time together as possible, with the children and grandchildren. Seeing Helen decline was difficult for us all."
Helen's passing left her husband Brent, their children Emily, 35, and Benjamin, 33, along with grandchildren Penny, six, Nora, four, Isaac, three, and Rhoda, one, to cherish her memory.

Brent added: "Helen lived for her family. She was looking forward to reducing her work hours so she could help care for our grandchildren.
"That's what hurts the most, she never got to enjoy the role she was so excited for. All she ever wanted was to be a young nan, but this cruel disease robbed her of that."
In Helen's honour, Brent and his loved ones have collected over £5,700 for Brain Tumour Research, which will support two full days of research at one of the charity's Centres of Excellence. To commemorate Father's Day, Brent undertook a skydive from 10,000 feet in remembrance of Helen.

Brent said: "Our family has been robbed of a wife, mother and grandmother and more funding is desperately needed for research. Without it, other families will continue to face the same heartbreak we've been going through."
Around 3,200 people in the UK are diagnosed with glioblastoma every year, yet only about 160 will survive beyond five years. Glioblastoma represents a third of all primary brain tumour cases, and the current treatments offer scant hope for a long-term cure.
Letty Greenfield, community development manager at Brain Tumour Research, said: "Helen's story is heartbreaking and all too common. Glioblastoma is an aggressive brain cancer with limited treatment options and a devastating prognosis.
"We are incredibly grateful to Brent and his family for honouring Helen's memory through their fundraising. It's support like this that helps us push for better outcomes and ultimately a cure."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Fast MRI breast screening hopes to find cancers earlier
Fast MRI breast screening hopes to find cancers earlier

BBC News

time2 hours ago

  • BBC News

Fast MRI breast screening hopes to find cancers earlier

A new breast cancer study is looking at whether a fast MRI scan might help find "hard to spot" tumours Fast MRI Dyamond study is being led by North Bristol NHS Trust and will scan about 1,000 women, aged 50 to 52, across six NHS sites, including Cheltenham, Swindon and is hoped the MRI scan – which is carried out in around three minutes - will detect breast cancers that may not be picked up routinely by mammograms in women with average breast Lyn Jones, consultant radiologist and the study lead, believes lives could be saved, adding: "We know that Fast MRI can find cancers earlier than mammograms for women with dense breasts." One of those joining the three and a half year study is Diana Dalgliesh, whose sister Alison died in 2023 from breast cancer in her Dalgliesh, who works at Southmead Hospital, said: "Her breast cancer was not picked up on a mammogram which she'd had only a few months before her diagnosis."Perhaps if there had been a different way of screening it might have been [picked up], so I thought if I am able to have an MRI scan, it may detect things earlier than if I just had a mammogram alone."Ms Dalgliesh said she has "little doubt" her sister's cancer would have been picked up earlier, if she had the option of an MRI."I know the type of cancer she had is more easily seen on an MRI than a mammogram, whether it would have changed the outcome I don't know," she added. At age 50 to 52, breasts can look both completely white or dark on appearances are normal, as are all the different combinations of white and dark in between. These differences are called mammographic density or breast breast density can make a small cancer difficult to spot on a Fast MRI is a shortened form of a breast MRI scan that has already been proven to find aggressive cancers smaller than a centimetre for women with dense benefits of Fast MRI include there being no need to flatten the breast – which can cause discomfort and no need for radiation (X-rays).Jointly funded by grants of £1.36m from the Medical Research Council and the National Institute for Health and Care Research (NIHR), it will be the first time in the UK that breast MRI scans will be offered to women with average breast density at their routine screening mammogram. Janice Rose, from Independent Cancer Patients' Voice, a patient advocate group, said the Fast MRI technology "could have a huge benefit to women entering the screening programme"."Early diagnosis for breast cancer gives women the best possible outcome," she NHS Breast Screening Programme offers women aged 50 to 70 years old a mammogram every three detecting breast cancers before they can be seen or felt, breast screening already saves around 1,300 lives each year in the UK.

Breast cancer warning issued to all women as common sign won't always appear
Breast cancer warning issued to all women as common sign won't always appear

Daily Mirror

timea day ago

  • Daily Mirror

Breast cancer warning issued to all women as common sign won't always appear

More difficult to notice and poorly understood, lobular breast cancer is finally coming under the spotlight but it's not as easy to spot the signs, especially one common one woman look for Lobular breast cancer, also known as invasive lobular carcinoma (ILC), is more common than ovarian and skin cancer yet there is little awareness of it. According to Cancer Research UK, one in seven women will be diagnosed with breast cancer in their lifetime and around 15% of those will have ILC. ‌ BBC presenter Victoria Derbyshire, 56, was diagnosed with the disease in 2015. ILC is different to the most common form of ductal breast cancer. Instead of starting in the breast ducts, it starts in the lobules, the glands that produce milk, and grows in a spider's web pattern. Cancer cells infect the tissue around the glands and rarely show in lumps, so it is harder to spot and likely to be diagnosed later. ‌ At least a fifth of ILC cases return years later. When this happens, the cancer becomes even harder to treat. And yet it's an under-diagnosed subtype of breast cancer that is underfunded and poorly understood. ‌ Kate Ford, a campaigner from the Lobular MoonShot Project (LMSP), says, 'The basic biology of this disease has never been studied and it has no specific treatment. ILC needs a moon shot approach – a fast injection of cash – to research funding.' On 24 June, 22 women led by LMSP Founder Dr Susan Michaelis, who sadly passed away from ILC on 9 July, held a vigil outside 10 Downing Street and delivered a petition backed by more than 350 MPs to the Prime Minister, calling for urgent funding for ILC research. ‌ Symptoms to watch out for Lobular breast cancer rarely forms lumps. Instead, the things to look out for include an area of thickening or swelling around the breast, a change in the nipple, for example it becoming inverted, or a change in the skin, such as dimpling, puckering or even a small new mark. Don't ignore other changes ‌ Cancer Research UK suggests people should also look out for pain and itching, a new lump in your breast or armpit, a change in the size, shape or feel of your breast, skin changes in the breast such as a rash or redness of the skin, fluid leaking from the nipple in a woman who isn't pregnant or breastfeeding and/or changes in the position of the nipple. If you see any of these symptoms you're advised to visit your doctor. Get a diagnosis Your GP will refer you to a clinic if they believe you might have ILC. They will examine your breasts and check for swollen lymph nodes. They may use a mammogram, an ultrasound if you're under 35, a biopsy or an MRI scan. MRI and biopsy are the most effective detection tools for ILC. Mammograms and ultrasound often fail to show the presence of the disease. ‌ How ILC is treated ILC is currently treated with chemotherapy, surgery and drugs to reduce the level of oestrogen, which cancer cells need to grow. Chemo works best on fast-dividing cells, but lobular breast cancer is not fast dividing, so the efficacy of chemo on ILC is not entirely understood. Depending on the size and abnormality, whether cells have receptors for drugs, your general health and age, a doctor will consider the best treatment, but generally it is the same as for the more common types of breast cancer. Hope for the future ‌ The Lobular Moon Shot Project is campaigning to raise £20min government funding to carry out vital research on ILC in partnership with the Manchester Breast Centre and led by breast biology expert Professor Rob Clarke.'With this funding, we could potentially develop a drug and begin testing it on patients within the next five years,' he says. "The fear of recurrence is always with me" Lobular Moon Shot Project campaigner, teacher and mum-of-three Katie Swinburne, 49, was diagnosed with ILC in 2023. ‌ 'Prior to my diagnosis, I was extremely fit and healthy, and took care with the food I ate. I remember the morning I found a lump very clearly. It appeared overnight after two years of other symptoms including pain and itching. It was extremely large, but in my ignorance I thought it was a cyst. 'I went to see my GP and was sent to have a mammogram, the nan ultrasound. The sonographer felt the lump but was confident there was nothing to worry about. He performed a biopsy to try and establish what the lump was. ‌ 'At my next appointment, a consultant came in, followed by a nurse. I was soon to learn the nurse was a Macmillan nurse. I was smiling and chatting away to the consultant, expecting to be sent on my way, when he said, 'We have the results – you have an invasive lobular carcinoma.' 'Hearing the words 'you have cancer' is like nothing else. My life, my body and my future were no longer assured. At the time of my diagnosis, my children were 10, 12 and 14. The thought of leaving them left me breathless. 'A whirlwind of appointments followed, including CT, MRI and DEXA scans. I had a double mastectomy and dose-dense chemotherapy, then radiotherapy. The nurses are angels. They hold your hand through it all. You find reserves you never knew you had. 'The fear of recurrence is always with me. I'm two years on from diagnosis and still too young for screening. Had that lump not appeared, my story might be very different. I think we need to start education and screening at a much younger age.' The Macmillan Support Line offers free, confidential support to people living with cancer and their loved ones. Call for free within the UK on 0808 808 0000

Hospital horror as boy, 6, killed in MRI machine by flying oxygen tank
Hospital horror as boy, 6, killed in MRI machine by flying oxygen tank

Daily Record

time3 days ago

  • Daily Record

Hospital horror as boy, 6, killed in MRI machine by flying oxygen tank

Michael Colombini, of Croton-On-Hudson, died two days after the 2001 mishap at Westchester Medical Center, in Valhalla, which was caused by the oxygen tank becoming magnetised In a shocking tragedy that stunned New York and the entire US, a six-year-old lost his life when a flying oxygen cylinder struck him during a Magnetic Resonance Imaging (MRI) scan. ‌ The metal container, hurtling at speeds of 20 to 30 feet per second, caused fatal skull injuries to Michael Colombini, from Croton-On-Hudson, after being pulled in by the MRI's massive 10-tonne electromagnet. ‌ Tragically, Michael died two days following the horrific accident at Westchester Medical Center, located north of New York City, roughly an hour's journey from where a 61 year old gentleman recently perished after being dragged into an MRI scanner whilst wearing a heavy metallic chain at Nassau Open MRI in Westbury. ‌ Officials say Keith McAllister, who lost his life on July 17, had moved towards the apparatus after his spouse, who was having a scan, cried out for assistance. Back in 2001, when Michael was fatally injured, hospital authorities confirmed the oxygen cylinder was "immediately magnetised and drawn to the centre of the machine, causing head trauma to the child.", reports the Mirror. An MRI scanner is a medical imaging apparatus that utilises powerful magnetic forces and radio frequencies to produce comprehensive images of a patient's internal body structure, enabling medics to identify and track numerous health conditions. ‌ Following sedation, Michael was positioned inside one of these devices for examination after having a non-cancerous brain growth surgically removed, but whilst inside the scanner his oxygen levels plummeted rapidly. Staff tried to rectify the situation using the suite's built-in oxygen supply, but their efforts were in vain. They then made the fatal decision to bring a portable steel oxygen tank into the room. ‌ The magnetic pull was so powerful that an anaesthesiologist had the cannister yanked from their grip and into the scanner as soon as they received it at the doorway. The cannister struck Michael, leading to his tragic death. In October 2009, Michael's parents secured a $2.9 million legal settlement with Westchester County Health Care of Valhalla, as disclosed by a New York court in 2010. Over 500 people attended the six year old's funeral, where his kindergarten teacher, Diana Heaton, described him as "an awesome kid who liked having fun," adding "we're all shocked and saddened by this." ‌ Approximately 100 hospital employees attended a prayer service for Michael. In a statement, the boy's family expressed gratitude for ''the outpouring of public sympathy," but requested privacy as they were "unable to make any public remarks regarding the loss of their beloved son Michael" because they had "just begun the grieving process." As part of the 2009 settlement, the parties agreed not to comment on the accident or litigation, although none sought to seal the legal records. Edward Stolzenberg, then-president and chief executive officer of the medical centre, stated at the time that the facility would "do anything it can to ease the family's grief. " He further stated: "The trauma was due to what can only be described as a horrific accident, and the entire medical centre is grieving."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store